chrX-43949789-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000266.4(NDP):c.*10C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,164,724 control chromosomes in the GnomAD database, including 10 homozygotes. There are 322 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 5 hom., 168 hem., cov: 22)
Exomes 𝑓: 0.00057 ( 5 hom. 154 hem. )
Consequence
NDP
NM_000266.4 3_prime_UTR
NM_000266.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0610
Genes affected
NDP (HGNC:7678): (norrin cystine knot growth factor NDP) This gene encodes a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin pathway. The protein forms disulfide-linked oligomers in the extracellular matrix. Mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant X-43949789-G-C is Benign according to our data. Variant chrX-43949789-G-C is described in ClinVar as [Benign]. Clinvar id is 167324.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00573 (643/112134) while in subpopulation AFR AF= 0.0202 (623/30839). AF 95% confidence interval is 0.0189. There are 5 homozygotes in gnomad4. There are 168 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDP | ENST00000642620 | c.*10C>G | 3_prime_UTR_variant | 3/3 | NM_000266.4 | ENSP00000495972.1 | ||||
NDP | ENST00000647044 | c.*10C>G | 3_prime_UTR_variant | 4/4 | ENSP00000495811.1 | |||||
NDP-AS1 | ENST00000435093.1 | n.58G>C | non_coding_transcript_exon_variant | 1/5 | 3 | |||||
NDP | ENST00000470584.1 | n.456C>G | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00571 AC: 640AN: 112079Hom.: 5 Cov.: 22 AF XY: 0.00488 AC XY: 167AN XY: 34231
GnomAD3 genomes
AF:
AC:
640
AN:
112079
Hom.:
Cov.:
22
AF XY:
AC XY:
167
AN XY:
34231
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00130 AC: 154AN: 118798Hom.: 1 AF XY: 0.000879 AC XY: 36AN XY: 40968
GnomAD3 exomes
AF:
AC:
154
AN:
118798
Hom.:
AF XY:
AC XY:
36
AN XY:
40968
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000567 AC: 597AN: 1052590Hom.: 5 Cov.: 28 AF XY: 0.000451 AC XY: 154AN XY: 341634
GnomAD4 exome
AF:
AC:
597
AN:
1052590
Hom.:
Cov.:
28
AF XY:
AC XY:
154
AN XY:
341634
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00573 AC: 643AN: 112134Hom.: 5 Cov.: 22 AF XY: 0.00490 AC XY: 168AN XY: 34296
GnomAD4 genome
AF:
AC:
643
AN:
112134
Hom.:
Cov.:
22
AF XY:
AC XY:
168
AN XY:
34296
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 30, 2014 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 25, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at